Published • loading... • Updated
From US$84,000 to US$57: Why affordable hepatitis C treatment still isn't reaching millions
Summary by Clinton Health Access Initiative
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
From US$84,000 to US$57: Why affordable hepatitis C treatment still isn't reaching millions
CHAI is pleased to release the 2026 Hepatitis C Treatment Market Memo, the latest in our series of hepatitis C market intelligence publications. A decade ago, curing hepatitis C cost more than US$84,000 per patient. Today, the same cure can be procured at around US$60 per patient. Few global health markets have changed so dramatically. Yet despite this transformation, millions of people who have already been diagnosed with hepatitis C still cann…
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
